Literature DB >> 8274822

Synergistic embryotoxicity of combination pyrimethamine and folic acid in rats.

M K Chung1, S S Han, J K Roh.   

Abstract

The increased embryotoxicity of pyrimethamine (PYM) with concomitant oral dosing of folic acid (FA) was examined in rats. The preventive effects of folinic acid (FNA) on PYM embryotoxicity were also examined. Six groups were constructed: PYM I (PYM 1.2 mg/kg/day), FA (FA 50 mg/kg/day), PYM I+FA (1.2 and 50 mg/kg/day, respectively), PYM II (2.7 mg/kg/day), PYM II+FNA (2.7 and 12 mg/kg/day, respectively), and a vehicle control group. The agents were administered for 11 days from day 7 throughout 17 of gestation. PYM and FA were administered by gavage and FNA was administered intraperitoneally. Visceral and skeletal malformations were observed in the fetuses of both PYM I+FA and PYM II groups; these included dilatation of the lateral ventricle and fused ribs. No malformed fetuses were observed in the fetuses of the other four groups. External malformations were observed only in the fetuses of PYM II groups; these included cleft palate, cleft lips, and brachygnathia, among others. These results show that the concomitant gavage dosing of FA augments PYM embryotoxicity. The preventive effects of FNA were also confirmed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8274822     DOI: 10.1016/0890-6238(93)90091-k

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  4 in total

1.  Role of farletuzumab in epithelial ovarian carcinoma.

Authors:  Danijela Jelovac; Deborah K Armstrong
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 2.  Immunotherapy in ovarian cancer.

Authors:  Gina M Mantia-Smaldone; Bradley Corr; Christina S Chu
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

3.  Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies.

Authors:  Gina M Mantia-Smaldone; Robert P Edwards; Anda M Vlad
Journal:  Cancer Manag Res       Date:  2010-12-30       Impact factor: 3.989

Review 4.  Equine Protozoal Myeloencephalitis: An Updated Consensus Statement with a Focus on Parasite Biology, Diagnosis, Treatment, and Prevention.

Authors:  S M Reed; M Furr; D K Howe; A L Johnson; R J MacKay; J K Morrow; N Pusterla; S Witonsky
Journal:  J Vet Intern Med       Date:  2016-02-09       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.